As pediatric AML with MNX1 activation has a different activation event, does not have chr7q deletions or BCOR mutations, and is seen in infants at a different developmental state, the overlap of dysregulated key genes strongly connects the observed gene dysregulation to MNX1 activity and not to confounding factors. The gene discussed is BCOR; the disease is acute myeloid leukemia.